Related Experiment Video
Updated: Oct 26, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Understanding the DNA double-strand break repair and its therapeutic implications
Ujjayinee Ray1, Sathees C Raghavan1
1Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India.
Abstract:
Repair of DNA double-strand breaks (DSBs) and its regulation are tightly integrated inside cells. Homologous recombination, nonhomologous end joining and microhomology mediated end joining are three major DSB repair pathways in mammalian cells. Targeting proteins associated with these repair pathways using small molecule inhibitors can prove effective in tumors, especially those with deregulated repair. Sensitization of cancer to current age therapy including radio and chemotherapy, using small molecule inhibitors is promising and warrant further development. Although several are under clinical trial, till date no repair inhibitor is approved for commercial use in cancer patients, with the exception of PARP inhibitors targeting single-strand break repair. Based on molecular profiling of repair proteins, better prognostic and therapeutic output can be achieved in patients. In the present review, we highlight the different mechanisms of DSB repair, chromatin dynamics to provide repair accessibility and modulation of inhibitors in association with molecular profiling and current gold standard treatment modalities for cancer.
Insights
Targeting DNA double-strand break (DSB) repair pathways with small molecule inhibitors shows promise for cancer therapy. Molecular profiling of repair proteins can improve patient outcomes when combined with existing treatments.
Area of Science:
- Molecular Biology
- Cancer Therapeutics
- Genetics
Background:
- DNA double-strand breaks (DSBs) are critical DNA lesions repaired by homologous recombination, nonhomologous end joining, and microhomology-mediated end joining.
- Targeting these DSB repair pathways with small molecule inhibitors offers a strategy to enhance cancer treatment efficacy, particularly in tumors with altered repair mechanisms.
Purpose of the Study:
- To review the mechanisms of DSB repair and chromatin dynamics.
- To discuss the modulation of small molecule inhibitors in cancer therapy.
- To explore the integration of molecular profiling with current cancer treatment modalities.
Main Methods:
- Review of existing literature on DNA double-strand break repair pathways.
- Analysis of small molecule inhibitors targeting DSB repair proteins.
- Discussion of chromatin dynamics in DNA repair accessibility.
- Integration of molecular profiling with therapeutic strategies.
Main Results:
- Small molecule inhibitors targeting DSB repair pathways can sensitize tumors to radio and chemotherapy.
- While several inhibitors are in clinical trials, only PARP inhibitors (targeting single-strand break repair) are approved.
- Molecular profiling of repair proteins can guide prognostic and therapeutic decisions.
Conclusions:
- Targeting DSB repair pathways is a promising strategy for cancer treatment.
- Further development of small molecule inhibitors and integration with molecular profiling are warranted.
- Combination therapy with existing treatments and personalized approaches can improve patient outcomes.
More Related Videos
08:31Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
06:59Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
Related Concept Videos
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Homologous Recombination
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Long-patch Base Excision Repair